- Country: Japan
- Summary: EVRYSDI Dry Syrup 60 912 units,ARIKAYCE Inhalation solution 590 1176 units,IMDELLTRA For I.V. Infusion 10 24 units,EVRYSDI Tablets 5 514units,ULTOMIRIS for Intravenous Infusion 3003144 un...
- JPT Ref No: 124833117
- Deadline: 30 Sep 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.:
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- EVRYSDI Dry Syrup 60 912 units,ARIKAYCE Inhalation solution 590 1176 units,IMDELLTRA For I.V. Infusion 10 24 units,EVRYSDI Tablets 5 514units,ULTOMIRIS for Intravenous Infusion 3003144 un...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINEVRYSDI Dry Syrup 60 912 units,ARIKAYCE Inhalation solution 590 1176 units,IMDELLTRA For I.V. Infusion 10 24 units,EVRYSDI Tablets 5 514units,ULTOMIRIS for Intravenous Infusion 3003144 un... - Japan Tender
The NATIONAL HOSPITAL ORGANIZATION, a Government sector organization in Japan, has announced a new tender for EVRYSDI Dry Syrup 60 912 units,ARIKAYCE Inhalation solution 590 1176 units,IMDELLTRA For I.V. Infusion 10 24 units,EVRYSDI Tablets 5 514units,ULTOMIRIS for Intravenous Infusion 3003144 un.... This tender is published on JapanTenders under JPT Ref No: 124833117 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-30.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
